Access Statistics for Christopher James Sampson

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Framework for Value-aligned Pricing of Combination Therapies 0 1 4 5 0 1 6 10
Barriers to Uptake of Minimal Access Surgery in the United Kingdom 0 0 1 2 0 2 6 12
Cost implications of treatment non-completion in a forensic personality disorder service 0 0 0 15 1 1 2 44
Drop Dead: Is Anchoring at ‘Dead’ a Theoretical Requirement in Health State Valuation? 0 0 1 9 1 1 9 29
Happy and healthy: a joint model of health and life satisfaction 0 0 0 87 0 0 4 287
How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy 0 1 2 29 2 7 11 97
How is Quality of Life Measured for Health Technology Assessments? 0 1 2 16 0 2 10 42
R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C 0 0 1 1 0 0 2 5
The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe 1 2 5 7 2 4 12 17
The Impact of New Medicines in the NHS: 70 Years of Innovation 0 0 0 1 3 4 7 11
The relationship between individual risk and cost-effectiveness in screening interventions 0 0 1 43 0 0 4 292
Total Working Papers 1 5 17 215 9 22 73 846
4 registered items for which data could not be found


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Do patients registered with CAM-trained GPs really use fewer health care resources and live longer? A response to Kooreman and Baars. Eur J Health Econ (2012). 13:469–776 0 0 0 3 3 5 8 85
Health Opportunity Costs and Expert Elicitation: A Comment on Soares et al 0 0 0 1 1 1 3 8
Is anchoring at ‘dead’ a theoretical requirement for health state valuation? 0 0 0 1 0 0 2 6
Marginal cost per QALY estimates: What are they good for? 0 1 7 10 3 9 33 46
Model Registration: A Call to Action 0 0 0 4 0 2 3 63
NICE and the EQ-5D-5L: Ten Years Trouble 0 0 0 3 1 2 6 20
Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy 3 13 24 24 10 47 116 123
Transparency in Decision Modelling: What, Why, Who and How? 0 0 0 4 3 7 9 59
Total Journal Articles 3 14 31 50 21 73 180 410


Statistics updated 2025-12-06